Assessment of resectability of pancreatic cancer using novel immersive high-performance virtual reality rendering of abdominal computed tomography and magnetic resonance imaging - Scorecard - MDSpire
Advertisement
Assessment of resectability of pancreatic cancer using novel immersive high-performance virtual reality rendering of abdominal computed tomography and magnetic resonance imaging
Clinical Scorecard: Evaluation of Pancreatic Cancer Resectability Through Advanced Virtual Reality Visualization of Abdominal CT and MRI Scans
At a Glance
Category
Detail
Condition
Pancreatic ductal adenocarcinoma (PDAC)
Key Mechanisms
Use of VR software (Specto VR™) to render and interact with 3D models from CT and MRI imaging for improved anatomical understanding and resectability assessment
Target Population
Clinicians assessing PDAC resectability; patients with pathology or cytology proven PDAC undergoing imaging
Care Setting
Hospital settings including surgical, radiological, and oncological departments
Key Highlights
VR software enables real-time 3D rendering and interactive visualization of cross-sectional CT and MRI images.
Current PDAC resectability assessment relies on 2D imaging with low inter-observer agreement; VR may improve accuracy and understanding.
Study evaluates usability and anatomical recognition of VR models by clinicians and specialists to support surgical planning.
Guideline-Based Recommendations
Diagnosis
Use contrast-enhanced CT or MRI imaging to assess local resectability of PDAC as per NCCN guidelines.
Classify PDAC resectability into Resectable (R), Borderline Resectable (BR), and Locally Advanced (LA) categories.
Management
Consider VR-enhanced visualization as an adjunct tool to improve surgical and oncological treatment planning.
Use multidisciplinary team discussions integrating imaging and clinical data for treatment decisions.
Monitoring & Follow-up
Monitor imaging findings and surgical outcomes to refine resectability assessment and VR tool utility.
Risks
Recognize that PDAC resectability represents a clinical continuum, complicating clear-cut decisions.
Be aware of current limitations in inter-observer agreement on 2D imaging assessments.
Patient & Prescribing Data
Patients with confirmed PDAC undergoing CT or MRI staging
VR visualization may enhance preoperative planning but is currently investigational and adjunctive to standard imaging.
Clinical Best Practices
Provide clinicians with training and acclimatization to VR environments before clinical use.
Use VR to supplement, not replace, standard imaging interpretation and multidisciplinary evaluation.
Incorporate VR tools compatible with PACS for seamless integration into clinical workflow.
Engage specialists in hepatobiliary and pancreatic surgery and radiology for VR-based resectability assessments.
by Julia Madlaina Kunz, Peter Maloca, Andreas Allemann, David Fasler, Savas Soysal, Silvio Däster, Marko Kraljević, Gulbahar Syeda, Benjamin Weixler, Christian Nebiker, Vincent Ochs, Raoul Droeser, Harriet Louise Walker, Martin Bolli, Beat Müller, Philippe Cattin, Sebastian Manuel Staubli
